ストックスクリーナーアプリを入手
3.14
9.22%
0.265
アフターアワーズ：
3.14
前日終値:
$2.875
開ける：
$2.88
24時間の取引高:
324.48K
Relative Volume:
1.57
時価総額：
$92.72M
収益：
-
当期純損益:
-
株価収益率:
-1.5871
EPS:
-1.9784
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+21.71%
1か月 パフォーマンス:
-39.32%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$2.8547
$3.2489
1週間の範囲:
$2.60
$3.2489
52週間の値動き範囲:
$2.34
$8.79
Anteris Technologies Global Corp Stock (AVR) Company Profile
名前
Anteris Technologies Global Corp
セクター
電話
651-493-0606
住所
860 BLUE GENTIAN ROAD, EAGAN
AVR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
3.14 | 92.72M | 0 | 0 | 0 | -1.9784 |
|
ISRG
Intuitive Surgical Inc
|
468.32 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
196.61 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
91.38 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
210.87 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
78.70 | 15.58B | 3.90B | 392.30M | 288.10M | 1.95 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-08 | 開始されました | Lake Street | Buy |
| 2025-01-07 | 開始されました | Barclays | Overweight |
| 2025-01-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-01-07 | 開始されました | TD Cowen | Buy |
Anteris Technologies Global Corp (AVR) 最新ニュース
Cantor Fitzgerald maintains Anteris stock Overweight with $9 target By Investing.com - Investing.com India
Anteris Technologies Announces Cessation of Securities - TipRanks
Anteris Technologies Announces New Securities Quotation - TipRanks
NanoVibronix (NASDAQ:NAOV) & Anteris Technologies Global (NASDAQ:AVR) Head to Head Review - Defense World
Anteris Technologies Reports March 2025 CDI Adjustments - TipRanks
Anteris Technologies Marks Clinical Milestone with DurAVR® THV By Investing.com - Investing.com Canada
Anteris reports over 100 patients treated with new heart valve By Investing.com - Investing.com South Africa
Anteris Technologies Hits Milestone with DurAVR® Heart Valve Treatment - Zenopa
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV - GlobeNewswire
Anteris reports over 100 patients treated with new heart valve - Investing.com
Anteris Technologies announces 100 patients treated with DurAVR THV - TipRanks
Anteris Technologies Achieves Key Milestone in Cardiac Care - TipRanks
Anteris Technologies Marks Clinical Milestone with DurAVR® THV - Investing.com
Anteris Technologies Achieves Milestone with DurAVR® Heart Valve - TipRanks
Anteris Technologies marks clinical milestone with more than 100 patients treated using flagship DurAVR® THV - Proactive financial news
ASX Health Stocks: Anteris plans for US IPO and listing on Nasdaq - MSN
Head to Head Survey: Anteris Technologies Global (NASDAQ:AVR) & United Health Products (OTCMKTS:UEEC) - Defense World
Anteris Technologies reports one-year patient outcomes for DurAVR THV - TipRanks
Anteris shares rise on positive valve trial results By Investing.com - Investing.com Canada
Anteris Reports One-Year Patient Outcomes for DurAVR® THV - The Manila Times
Anteris shares rise on positive valve trial results - Investing.com India
Anteris Technologies Unveils Positive DurAVR® Patient Outcomes - TipRanks
Anteris Technologies delivers strong one-year results for DurAVR® Transcatheter Heart Valve - Proactive financial news
Analyzing Anteris Technologies Global (NASDAQ:AVR) & CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World
Anteris Technologies Global (NASDAQ:AVR) Stock Price Down 6.2% – What’s Next? - Defense World
Anteris Technologies: Advancing Toward FDA Approval with Positive Buy Rating - TipRanks
Anteris Technologies reports annual financial results By Investing.com - Investing.com South Africa
Anteris Technologies reports annual financial results - Investing.com India
Anteris Reports 2024 Financial Results and Provides Corporate Update - The Manila Times
Anteris Technologies: A Trailblazing Year of Innovation and Expansion - Kondor EXP
The morning catch up: ASX to reverse losses despite war of words over tariffs - Proactive financial news
Anteris Technologies: A Transformational Leap with Its Nasdaq Debut and Heart Valve Breakthroughs - Kondor EXP
Anteris Technologies 2024 financials strong following Nasdaq debut, with plans for heart valve pivotal trial this year - Proactive Investors USA
Proactive financial news: fast, accessible, and actionable articles and videos for the global investment audience. - Proactive Investors Australia
Anteris Technologies Reports 2024 Financial Results and Advances Heart Valve Innovations - TipRanks
Anteris Technologies Reports Increased Losses Amid Strategic Reorganization - TipRanks
Anteris Technologies Global Corp. (AVR) reports earnings - Quartz
Small cap wrap: Ocean Power Technologies, Zero Candida, Liberty Star Minerals... - Proactive Investors UK
Anteris Technologies Issues New Shares to Bolster Financial Position - TipRanks
Anteris Technologies appoints David St Denis as President and Class II director - Proactive financial news
Anteris Technologies Global Corp (AVR) 財務データ
収益
当期純利益
現金流量
EPS
3.50%
0.47%
大文字化:
|
ボリューム (24 時間):